Vericel (VCEL) Other financing activities (2010 - 2026)
Vericel (VCEL) reported Other financing activities of -$21000.0 for Q1 2026, down 425.0% on a YoY basis from $6461.5 in Q1 2025, and little changed sequentially from -$21000.0 in Q4 2025.
Vericel (VCEL) Other financing activities (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 10 years of Other financing activities data on file, last reported at -$21000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities fell 425.0% year-over-year to -$21000.0; the trailing twelve-month figure through Mar 2026 stood at -$64000.0 (down 1500.0% YoY), and the FY2025 full-year result was -$47000.0, changed N/A from the prior year.
- Other financing activities held at -$21000.0 in Q1 2026, from -$21000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1000.0 in Q2 2022 to a low of -$21000.0 in Q3 2022.
- A 4-year average of -$13454.5 and a median of -$19000.0 in 2022 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities jumped 100.03% in 2022 and plunged 425.0% in 2026, its largest moves.
- Tracing VCEL's Other financing activities over 4 years: stood at -$21000.0 in 2022, then changed by 0.0% to -$21000.0 in 2023, then changed by 0.0% to -$21000.0 in 2025, then changed by 0.0% to -$21000.0 in 2026.
- Business Quant data shows VCEL's Other financing activities at -$21000.0 in Q1 2026, -$21000.0 in Q4 2025, and -$11000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |